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Abstract
Background: Anthrax lethal toxin (LT), produced by the Gram-positive bacterium Bacillus anthracis, is a highly
effective zinc dependent metalloprotease that cleaves the N-terminus of mitogen-activated protein kinase kinases
(MAPKK or MEKs) and is known to play a role in impairing the host immune system during an inhalation anthrax
infection. Here, we present the transcriptional responses of LT treated human monocytes in order to further
elucidate the mechanisms of LT inhibition on the host immune system.
Results: Western Blot analysis demonstrated cleavage of endogenous MEK1 and MEK3 when human monocytes
were treated with 500 ng/mL LT for four hours, proving their susceptibility to anthrax lethal toxin. Furthermore,
staining with annexin V and propidium iodide revealed that LT treatment did not induce human peripheral
monocyte apoptosis or necrosis. Using Affymetrix Human Genome U133 Plus 2.0 Arrays, we identified over 820
probe sets differentially regulated after LT treatment at the p <0.001 significance level, interrupting the normal
transduction of over 60 known pathways. As expected, the MAPKK signaling pathway was most drastically affected
by LT, but numerous genes outside the well-recognized pathways were also influenced by LT including the IL-18
signaling pathway, Toll-like receptor pathway and the IFN alpha signaling pathway. Multiple genes involved in actin
regulation, signal transduction, transcriptional regulation and cytokine signaling were identified after treatment with
anthrax LT.
Conclusion: We conclude LT directly targets human peripheral monocytes and causes multiple aberrant gene
responses that would be expected to be associated with defects in human monocyte’s normal signaling
transduction pathways and function. This study provides further insights into the mechanisms associated with the
host immune system collapse during an anthrax infection, and suggests that anthrax LT may have additional
downstream targets outside the well-known MAPK pathway.
Background
Bacillus anthracis, the causative agent of anthrax, is a
gram-positive bacterium that is naturally found in the
soil, and rarely affects the human population. Unfortu-
nately, deliberate dissemination of anthrax spores is
capable of delivering a highly potent and lethal air-borne
bioterrorist agent, as documented in the 2001 U.S. an-
thrax attacks. Inhalation anthrax is a highly fatal, acute
disease characterized by a rapid onset of systemic shock
and ultimately death [1].
The most virulent strains of B. anthracis contain two
plasmids, pXO2 and pXO1, encoding an antiphagocytic
poly-D-glutamic acid capsule and three exotoxins: lethal
factor, edema factor and protective antigen [2]. Protect-
ive antigen is an 83 kDa protein that is known to bind to
two host cell receptors, TEM-8 and CMG-2, facilitating
the entry of edema and/or lethal factor into host cells
[3]. Lethal factor is a 90 kDa zinc-dependent metallopro-
tease that cleaves the N-terminus of mitogen-activated
protein kinase kinases (MAPKKs or MEKs) [4,5]. Edema
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factor is an 89 kDa adenylate cyclase that increases
intracellular cAMP levels [6].
Previous studies using anthrax animal models have
documented resistance to anthrax lethal toxin (LT)
through depletion of host macrophages, suggesting that
these cells play a critical role in anthrax LT induced le-
thality [7,8]. LT has also been shown to suppress cyto-
kine responses by peripheral blood mononuclear cells,
induce macrophage apoptosis, and prevent monocyte
proliferation and differentiation [1,9,10]. Inhalation an-
thrax cases present clinical manifestations indicative of
host immune collapse in humans and in nonhuman pri-
mate studies [11-13]. However, more recent studies in-
vestigating human monocytes and macrophages have
suggested human alveolar macrophages are resistant to
LT, and undifferentiated human monocytic cell lines are
resistant to LT-induced death [10,14]. LT’s targeting of
human monocytes/macrophages could help to explain
the rapid onset of fatal symptoms and host demise dur-
ing an inhalation anthrax infection, but the exact effects
LT exerts on human peripheral monocytes, along with
the mechanisms underlying the impairment of the host
immune cell’s responses, have yet to be fully determined.
Previous studies investigating LT treated murine macro-
phages have shown a broad range in transcriptional effects
induced by LT. These studies concluded LT-induced
changes in macrophage inflammation, signaling, and tran-
scription factors, along with changes in the immune re-
sponse by macrophages. This study discovered the down
regulation of CD-137 after LT treatment, shown to play a
role in monocyte proliferation in response to LPS, and up
regulation of plasminogen activator inhibitor type I, which
results in fibrin deposits, massive imbalances in coagula-
tion, and, in some instances, multi-organ failure [15,16].
Another study has measured the transcriptional responses
of THP-1 cells after B. anthracis spore exposure, finding
toxigenic B. anthracis strains suppress the cell signaling
responses to infection [17].
Blood monocytes are mononuclear cells that play a
major role in the host immune response through
regulation of inflammatory responses, secretion of
cytokine and antimicrobial factors, and direct pathogen
clearance [18]. Monocytes are derived from monoblasts
in the bone marrow, and circulate in the blood for
1-2 days before they migrate into tissues where they re-
plenish the macrophage and dendritic pools [19-21].
Here, we determined human monocyte susceptibility to
LT by demonstrating cleavage of MEKs, and utilized
Affymetrix GeneChipW Human Genome U133 Plus 2.0
Arrays in order to identify additional mechanisms of LT
impairment on the transcriptional responses of human
peripheral monocytes. The arrays contained 54,675
probe sets representing over 22,000 of the best charac-
terized human genes, providing extensive insights into
the mechanisms behind LT induced dysfunction of human
peripheral monocytes.
This study is the first to determine direct human
monocyte susceptibility via cleavage of MEKs, along
with the analysis of the transcriptional responses, to
anthrax LT. The mechanisms of LT impairment on
human peripheral monocytes will help elucidate the
roles monocytes contribute during the host immune
system collapse documented during an anthrax infec-
tion. The transcriptional analysis will serve to not
only unravel the mechanisms behind the rapid onset
of death in anthrax victims, but will also potentially
provide new targets for controlling inflammation and
enhancing host defense.
Results and discussion
Monocyte purity, apoptosis and susceptibility to anthrax
LT
In order to first determine monocyte cell purity, iso-
lated cells were analyzed using flow cytometry and
gated using forward and side scatter, along with the
monocytic marker, CD14. It was found that mono-
cytes were isolated with a >85% purity (Figure 1A
and 1B). Because previous reports have documented
LT induced cell apoptosis, it was important to assure
the transcriptional response of LT treated monocytes
were independent of apoptosis. This was assured by
the analysis of the necrosis and apoptosis markers,
propidium iodide (PI) and annexin V, on human per-
ipheral monocytes. Nearly all (99%) human peripheral
monocytes showed no evidence of necrosis or apop-
tosis after a 4 h treatment of LT (Figure 1C and 1D).
There has been some conflicting data suggesting mono-
cytes, along with monocyte-derived cells, are not suscep-
tible to the actions of anthrax LT. One study utilized
human monocytic cell lines and found that undifferenti-
ated monocytic cells did not undergo LT-induced cytotox-
icity, while the differentiated cells were susceptible [10].
Another study investigating human alveolar macrophages
(AM) found that these cells were relatively resistant to the
actions of LT. It was ascertained that LT failed to suppress
human AM cytokine responses, cleave MEKs, and induce
apoptosis [14].
In order to explore the actions of LT on human per-
ipheral monocytes, a Western Blot analysis was per-
formed and MEK1, along with MEK3, cleavage was
determined after a 4-hour treatment with LT. Human
peripheral monocytes were found to be susceptible to
the actions of LT as evidenced by cleavage of MEK1 and
MEK3 (Figure 1E). HeLa cells were used as a positive
control and β-actin was used to assure equal loading
controls. We conclude that human peripheral mono-
cytes are a direct target of anthrax LT.
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Microarray analysis and results
Human peripheral monocytes were treated with LT or
media alone, and microarray analysis was performed using
four biological replicates from healthy volunteers. A total
of 8 microarray hybridizations were employed and ana-
lyzed on Affymetrix Gene ChipsW(HG U133 plus 2.0). The
chips contained 54,675 probe sets and identified multiple
differentially regulated pathways and genes by human per-
ipheral monocytes after LT treatment. Unsupervised hier-
archical analysis was used to assess the noise in the array
experiments. First, probe sets whose signal intensity varied
most in the data set were selected by applying a variation
filter. Probes sets that displayed a coefficient of variation of
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Figure 1 Monocyte purity, apoptosis, and susceptibility to LT. Red=CD14+ monocytes. Green =CD14-lymphocytes. A.) Forward and side
scatter analysis of purified fixed human monocytes showing the monocyte population as compared to total population. B.) CD14 Pacific Blue and
forward scatter analysis of fixed purified human monocytes showing >85% monocytes. C.) PI and annexin-FITC analysis of CD14+monocytes
after a 4 h incubation showing 99.0% viable cells indicated in quadrant 3. D.) PI and annexin-FITC analysis of CD14+monocytes after a 4 h LT
treatment showing 99.1% viable cells indicated in quadrant 3. HeLa cells or human monocytes were left untreated or treated with 500 ng/mL LT
for 4 h at 37°C. Samples were lysed, run on SDS-PAGE, transferred to PVDF membrane, and probed with indicated antibodies. Both MEK3 and
MEK1 were cleaved by LT while control cells showed no MEK cleavage. β-actin loading controls show equivalent loading of both control and LT
treated cells.
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clustering dendrogram showed the major node of separ-
ation between control and LT treated samples (Figure 2A).
To identify specific genes responsive to LT treatment,
a paired t-test (by donor) was performed at a signifi-
cance threshold of p< 0.001. Genes specified by 820
probe sets were found to be significant among the treat-
ment groups (Table 1). The hierarchical cluster pattern
of the significant probe sets is shown (Figure 3A). Of these
probe sets, multiple gene products known to play a role in
monocyte function were discovered (Figure 2B). The abil-
ity of probe sets significant at p< 0.001 to function as a
classifier between treatment groups (LT treated vs. con-
trol) was established by leave-one-out-cross-validation
and Monte Carlo simulations. Using 4 different prediction
models, the classifier performed flawlessly. Of the signifi-
cant genes identified, many are known to play a role in
monocyte function (Figure 2C).
Using the Gene Set Expression Comparison Analysis,
as implemented in BRB Array tools, the Biocarta path-
ways that were associated with the differentially regulated
genes were identified. Over 60 differentially regulated
pathways were discovered in monocytes in response to LT
treatment. As expected, the most significant pathway
affected by LT treatment was the MAPK signaling path-
way, with the p38 MAPK signaling pathway being most
impacted with 103 genes affected (Figure 3B). Additional
pathways altered by LT at the p< 0.001 significance level
included the IL-18, Toll-Like Receptor, IFN alpha, and G-
Protein Family signaling pathways. It is interesting to note
that a previous study measuring the transcriptional re-
sponse of human alveolar macrophages to anthrax spores
detected an activation of the TLR pathways [22], and our
results indicated anthrax LT targets 87 genes within the
TLR signaling pathway (Figure 3B).
RGS14 is a protein involved in the regulation of G-
protein signaling through attenuation of G-protein het-
erotrimer signaling, thereby inactivating this signaling
cascade. The Affymetrix microarrays revealed that RGS14
expression in LT treated monocytes showed a 6 fold in-
crease in expression (Table 2). This is a potentially signifi-
cant finding in that RGS14 inhibits G-proteins important
for chemotaxis. Therefore LT could be impairing chemo-
taxis not only by blocking Hsp27 phosphorylation through
disruption of the p38 pathway [23], but also by causing
(A)
(B)
38290_at Regulator of G-protein signaling 14 (Rgs14) 5.94 0.0009308
207008_at Interleukin 8 receptor, beta 5.04 0.0008868
210986_s_at Tropomyosin 1 (alpha) 3.49 0.0006411
212686_at Protein phosphatase 1H (PP2C domain containing) 2.65 0.0001409
226016_at CD47 molecule 2.40 0.0002531
211495_x_at Tumor necrosis factor (ligand) superfamily, member 13 2.25 0.0001799
209828_s_at Interleukin 16 (lymphocyte chemoattractant factor) 2.19 0.0001590
209269_s_at Spleen tyrosine kinase (Syk) 2.15 0.0007547
229497_at Ankyrin repeat and death domain containing 1A 2.1 0.0002478
206991_s_at Chemokine (C-C motif) receptor 5 (CCR5) -2.66 0.0009506
205403_at Interleukin 1 receptor, type II -12.04 0.0001070
Affymetrix
Probe ID            Gene or gene product name Fold change P-value















1 466 Yes Yes Yes Yes
2 261 Yes Yes Yes Yes
3 197 Yes Yes Yes Yes
4 199 Yes Yes Yes Yes
Correct 
Classification:
100% 100% 100% 100%
Performance of classifiers during cross-validation.(C)
Figure 2 Unsupervised microarray analysis. A.) Hierarchical clustering dendrogram showing similarities between expression patterns within
each condition. Specimens were paired based on donor, using 4 separate donors as indicated in replica r1 through r4. B.) Significant genes
(p< 0.001) up or down regulated after LT treatment, along with their fold change, p-value and probe ID. C.) Leave-one-out-cross validation was
used to calculate mis-classification rate that yielded a 100% correct classification between pairs.
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Probe set Gene symbol Description
1 2.80E-006 1.78 222001_x_at FAM91A2 family with sequence similarity 91, member A2
2 2.90E-006 1.25 218734_at NAT11 N-acetyltransferase 11
3 3.40E-006 1.6 230350_at NA NA
4 7.80E-006 1.56 228930_at NA NA
5 8.70E-006 1.58 208661_s_at TTC3 tetratricopeptide repeat domain 3
6 9.80E-006 1.16 218716_x_at MTO1 mitochondrial translation optimization 1 homolog (S. cerevisiae)
7 1.07E-005 1.15 238538_at ANKRD11 ankyrin repeat domain 11
8 1.22E-005 2.92 225896_at NA NA
9 1.41E-005 3.87 227450_at ERP27 endoplasmic reticulum protein 27 kDa
10 1.49E-005 1.23 226602_s_at BCR breakpoint cluster region
11 1.60E-005 1.65 209123_at QDPR quinoid dihydropteridine reductase
12 1.66E-005 1.73 213934_s_at ZNF23 zinc finger protein 23 (KOX 16)
13 1.66E-005 1.56 226419_s_at SFRS1 splicing factor, arginine/serine-rich 1
14 1.84E-005 2.91 227946_at OSBPL7 oxysterol binding protein-like 7
15 2.04E-005 1.84 242989_at NA NA
16 2.18E-005 1.92 242590_at NA NA
17 2.29E-005 1.36 204559_s_at LSM7 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae)
18 2.35E-005 1.68 225902_at NA NA
19 2.44E-005 1.29 220939_s_at DPP8 dipeptidyl-peptidase 8
20 2.63E-005 1.2 218682_s_at SLC4A1AP solute carrier family 4 (anion exchanger), member 1, adaptor protein
21 2.72E-005 2.21 212056_at KIAA0182 KIAA0182
22 2.91E-005 2.87 222477_s_at TM7SF3 transmembrane 7 superfamily member 3
23 3.01E-005 2.01 202512_s_at ATG5 ATG5 autophagy related 5 homolog (S. cerevisiae)
24 3.07E-005 1.52 209042_s_at UBE2G2 ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)
25 3.10E-005 5.25 232181_at LOC153346 hypothetical protein LOC153346
26 3.13E-005 1.79 1554452_a_at HIG2 hypoxia-inducible protein 2
27 3.36E-005 2.11 228772_at HNMT histamine N-methyltransferase
28 3.37E-005 1.3 221501_x_at LOC339047 hypothetical protein LOC339047
29 3.39E-005 1.81 239038_at C1orf52 chromosome 1 open reading frame 52
30 3.46E-005 1.95 203839_s_at TNK2 tyrosine kinase, non-receptor, 2
31 3.89E-005 1.89 227558_at CBX4 chromobox homolog 4 (Pc class homolog, Drosophila)
32 3.90E-005 1.4 214691_x_at FAM63B family with sequence similarity 63, member B
33 3.91E-005 1.32 228301_x_at NDUFB10 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa
34 4.05E-005 1.8 1556306_at NA NA
35 4.22E-005 3.27 229016_s_at TRERF1 transcriptional regulating factor 1
36 4.47E-005 3.85 223741_s_at TTYH2 tweety homolog 2 (Drosophila)
37 4.48E-005 5.6 49306_at RASSF4 Ras association (RalGDS/AF-6) domain family member 4
38 4.63E-005 1.49 32209_at FAM89B family with sequence similarity 89, member B
39 4.75E-005 2.83 225298_at PNKD paroxysmal nonkinesigenic dyskinesia
40 5.00E-005 1.59 228726_at NA NA
41 5.36E-005 1.17 1562984_at NA NA
42 5.39E-005 1.6 201639_s_at CPSF1 cleavage and polyadenylation specific factor 1, 160kDa
43 5.66E-005 1.47 221649_s_at PPAN peter pan homolog (Drosophila)
44 5.88E-005 1.94 225360_at TRABD TraB domain containing
45 6.23E-005 1.27 221005_s_at PTDSS2 phosphatidylserine synthase 2
46 6.35E-005 2.13 228914_at NA NA
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Table 1 Control vs Toxin corresponding P-value p<0.001 (Continued)
47 6.47E-005 1.65 208206_s_at RASGRP2 RAS guanyl releasing protein 2 (calcium and DAG-regulated)
48 6.49E-005 1.64 209198_s_at SYT11 synaptotagmin XI
49 6.55E-005 1.7 221575_at SCLY selenocysteine lyase
50 6.74E-005 1.82 229969_at NA NA
51 6.76E-005 2.22 235513_at NA NA
52 6.77E-005 1.93 236922_at NA NA
53 6.78E-005 1.14 204364_s_at REEP1 receptor accessory protein 1
54 6.87E-005 1.55 227025_at PPHLN1 periphilin 1
55 7.02E-005 1.78 227288_at SFRS12IP1 SFRS12-interacting protein 1
56 7.13E-005 2.55 205075_at SERPINF2 serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment
epithelium derived factor), member 2
57 7.16E-005 2.29 222988_s_at TMEM9 transmembrane protein 9
58 7.35E-005 1.39 231831_at COX19 COX19 cytochrome c oxidase assembly homolog (S. cerevisiae)
59 7.37E-005 1.88 221788_at NA NA
60 7.66E-005 1.61 236004_at NA NA
61 7.68E-005 1.85 219751_at SETD6 SET domain containing 6
62 7.92E-005 1.74 227273_at NA NA
63 8.67E-005 1.56 235787_at NA NA
64 8.91E-005 1.42 212888_at DICER1 dicer 1, ribonuclease type III
65 8.93E-005 1.93 1568593_a_at NUDT16P nudix (nucleoside diphosphate linked moiety X)-type motif 16
pseudogene
66 9.00E-005 1.92 226721_at DPY19L4 dpy-19-like 4 (C. elegans)
67 9.02E-005 1.39 227159_at GHDC GH3 domain containing
68 9.14E-005 2.36 225982_at UBTF upstream binding transcription factor, RNA polymerase I
69 9.25E-005 1.62 220341_s_at C5orf45 chromosome 5 open reading frame 45
70 9.51E-005 1.36 214501_s_at H2AFY H2A histone family, member Y
71 9.96E-005 7.6 226186_at NA NA
72 0.0001001 2.59 224946_s_at CCDC115 coiled-coil domain containing 115
73 0.0001056 1.66 237059_at NA NA
74 0.0001076 3.11 38671_at PLXND1 plexin D1
75 0.0001083 1.92 231912_s_at DKFZP434B0335 DKFZP434B0335 protein
76 0.0001087 1.55 238492_at NA NA
77 0.0001088 2.05 228548_at NA NA
78 0.0001089 1.9 225757_s_at CLMN calmin (calponin-like, transmembrane)
79 0.0001093 1.15 203926_x_at ATP5D ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit
80 0.0001100 1.41 232520_s_at NSFL1C NSFL1 (p97) cofactor (p47)
81 0.0001101 2.06 238012_at DPP7 dipeptidyl-peptidase 7
82 0.0001101 1.38 211101_x_at LILRA2 leukocyte immunoglobulin-like receptor, subfamily A (with TM domain),
member 2
83 0.0001109 1.35 210128_s_at LTB4R leukotriene B4 receptor
84 0.0001115 1.34 223393_s_at TSHZ3 teashirt zinc finger homeobox 3
85 0.0001123 1.46 213628_at CLCC1 chloride channel CLIC-like 1
86 0.0001152 1.27 214870_x_at LOC100132540 similar to LOC339047 protein
87 0.0001171 2.41 221756_at PIK3IP1 phosphoinositide-3-kinase interacting protein 1
88 0.0001171 1.62 222478_at VPS36 vacuolar protein sorting 36 homolog (S. cerevisiae)
89 0.0001192 1.99 225719_s_at MRPL55 mitochondrial ribosomal protein L55
90 0.0001206 1.87 212959_s_at GNPTAB N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
91 0.0001210 7.64 238520_at TRERF1 transcriptional regulating factor 1
92 0.0001235 3.04 226974_at NA NA
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Table 1 Control vs Toxin corresponding P-value p<0.001 (Continued)
93 0.0001269 2.06 225851_at FNTB farnesyltransferase, CAAX box, beta
94 0.0001288 2.04 224452_s_at MGC12966 hypothetical protein LOC84792
95 0.0001306 1.46 226092_at MPP5 membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
96 0.0001312 1.5 1558693_s_at C1orf85 chromosome 1 open reading frame 85
97 0.0001336 1.19 204020_at PURA purine-rich element binding protein A
98 0.0001350 1.73 1555882_at SPIN3 spindlin family, member 3
99 0.0001354 1.8 235532_at PIGM phosphatidylinositol glycan anchor biosynthesis, class M
100 0.0001371 2.61 1553111_a_at KBTBD6 kelch repeat and BTB (POZ) domain containing 6
101 0.0001408 1.44 227868_at LOC154761 hypothetical LOC154761
102 0.0001408 3.15 214058_at MYCL1 v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma
derived (avian)
103 0.0001409 2.65 212686_at PPM1H protein phosphatase 1H (PP2C domain containing)
104 0.0001414 1.61 218971_s_at WDR91 WD repeat domain 91
105 0.0001418 2.07 225777_at C9orf140 chromosome 9 open reading frame 140
106 0.0001426 1.92 225366_at PGM2 phosphoglucomutase 2
107 0.0001451 1.74 238768_at C2orf68 chromosome 2 open reading frame 68
108 0.0001454 1.49 218674_at C5orf44 chromosome 5 open reading frame 44
109 0.0001462 1.26 218490_s_at ZNF302 zinc finger protein 302
110 0.0001537 1.17 202704_at TOB1 transducer of ERBB2, 1
111 0.0001561 1.69 218361_at GOLPH3L golgi phosphoprotein 3-like
112 0.0001565 1.32 222994_at PRDX5 peroxiredoxin 5
113 0.0001590 2.19 209828_s_at IL16 interleukin 16 (lymphocyte chemoattractant factor)
114 0.0001593 1.47 204611_s_at PPP2R5B protein phosphatase 2, regulatory subunit B@#$%&, beta isoform
115 0.0001593 1.48 227730_at NA NA
116 0.0001599 1.14 228605_at NA NA
117 0.0001646 1.54 202135_s_at ACTR1B ARP1 actin-related protein 1 homolog B, centractin beta (yeast)
118 0.0001669 1.73 226183_at NA NA
119 0.0001709 1.88 65472_at C2orf68 chromosome 2 open reading frame 68
120 0.0001738 1.57 200098_s_at ANAPC5 anaphase promoting complex subunit 5
121 0.0001748 1.37 218181_s_at MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4
122 0.0001762 2.81 238135_at AGTRAP angiotensin II receptor-associated protein
123 0.0001767 3.66 203386_at TBC1D4 TBC1 domain family, member 4
124 0.0001784 2.06 213670_x_at NSUN5B NOL1/NOP2/Sun domain family, member 5B
125 0.0001787 1.69 212109_at HN1L hematological and neurological expressed 1-like
126 0.0001789 1.85 219968_at ZNF589 zinc finger protein 589
127 0.0001799 2.25 211495_x_at TNFSF13 tumor necrosis factor (ligand) superfamily, member 13
128 0.0001836 2.07 214177_s_at PBXIP1 pre-B-cell leukemia homeobox interacting protein 1
129 0.0001843 1.64 1554085_at DDX51 DEAD (Asp-Glu-Ala-Asp) box polypeptide 51
130 0.0001852 1.99 203271_s_at UNC119 unc-119 homolog (C. elegans)
131 0.0001878 1.43 226072_at FUK fucokinase
132 0.0001878 3.32 212235_at PLXND1 plexin D1
133 0.0001902 1.67 205658_s_at SNAPC4 small nuclear RNA activating complex, polypeptide 4, 190kDa
134 0.0001983 1.84 218021_at DHRS4 dehydrogenase/reductase (SDR family) member 4
135 0.0001987 1.76 229429_x_at FAM91A2 family with sequence similarity 91, member A2
136 0.0001990 1.27 212429_s_at GTF3C2 general transcription factor IIIC, polypeptide 2, beta 110kDa
137 0.0002007 1.81 226873_at NA NA
138 0.0002010 1.31 227801_at TRIM59 tripartite motif-containing 59
139 0.0002032 1.36 227679_at NA NA
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140 0.0002081 4.03 218326_s_at LGR4 leucine-rich repeat-containing G protein-coupled receptor 4
141 0.0002087 1.93 235252_at KSR1 kinase suppressor of ras 1
142 0.0002093 1.45 1558522_at NA NA
143 0.0002165 1.57 225396_at NA NA
144 0.0002167 1.4 206469_x_at AKR7A3 aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)
145 0.0002197 1.79 1563549_a_at ANO8 anoctamin 8
146 0.0002219 1.79 211576_s_at SLC19A1 solute carrier family 19 (folate transporter), member 1
147 0.0002234 1.35 202846_s_at PIGC phosphatidylinositol glycan anchor biosynthesis, class C
148 0.0002246 2.17 232231_at RUNX2 runt-related transcription factor 2
149 0.0002301 1.24 213480_at VAMP4 vesicle-associated membrane protein 4
150 0.0002335 1.57 1558755_x_at ZNF763 zinc finger protein 763
151 0.0002348 1.87 1557667_at NA NA
152 0.0002362 1.53 211036_x_at ANAPC5 anaphase promoting complex subunit 5
153 0.0002367 2.73 203387_s_at TBC1D4 TBC1 domain family, member 4
154 0.0002416 1.35 217896_s_at NIP30 NEFA-interacting nuclear protein NIP30
155 0.0002420 2.35 212136_at ATP2B4 ATPase, Ca++ transporting, plasma membrane 4
156 0.0002425 1.4 207618_s_at BCS1L BCS1-like (yeast)
157 0.0002450 1.85 239300_at NA NA
158 0.0002478 2.1 229497_at ANKDD1A ankyrin repeat and death domain containing 1A
159 0.0002509 1.29 214035_x_at LOC399491 LOC399491 protein
160 0.0002517 1.66 229874_x_at NA NA
161 0.0002521 1.74 221264_s_at LOC100128223 hypothetical protein LOC100128223
162 0.0002522 1.54 227630_at NA NA
163 0.0002531 2.4 226016_at CD47 CD47 molecule
164 0.0002559 1.53 1558947_at NA NA
165 0.0002582 2.08 222664_at KCTD15 potassium channel tetramerisation domain containing 15
166 0.0002606 4.49 207843_x_at CYB5A cytochrome b5 type A (microsomal)
167 0.0002633 2.1 218394_at ROGDI rogdi homolog (Drosophila)
168 0.0002634 1.86 214100_x_at NSUN5B NOL1/NOP2/Sun domain family, member 5B
169 0.0002641 1.4 212895_s_at ABR active BCR-related gene
170 0.0002648 2.01 227580_s_at DKFZP434B0335 DKFZP434B0335 protein
171 0.0002678 2.59 227253_at CP ceruloplasmin (ferroxidase)
172 0.0002679 1.78 230917_at NA NA
173 0.0002686 1.69 200843_s_at EPRS glutamyl-prolyl-tRNA synthetase
174 0.0002686 2.67 227346_at IKZF1 IKAROS family zinc finger 1 (Ikaros)
175 0.0002715 1.44 219095_at LOC100137047-
PLA2G4B
hypothetical protein LOC8681
176 0.0002762 1.68 229776_at SLCO3A1 solute carrier organic anion transporter family, member 3A1
177 0.0002768 4.48 226436_at RASSF4 Ras association (RalGDS/AF-6) domain family member 4
178 0.0002796 1.37 221951_at TMEM80 transmembrane protein 80
179 0.0002809 1.49 228606_at TM4SF19 transmembrane 4 L six family member 19
180 0.0002817 1.66 232535_at NA NA
181 0.0002826 1.28 1569597_at NA NA
182 0.0002831 1.77 1555845_at NA NA
183 0.0002835 2.77 205955_at NA NA
184 0.0002839 2.47 220137_at FLJ20674 hypothetical protein FLJ20674
185 0.0002845 2.56 218459_at TOR3A torsin family 3, member A
186 0.0002870 1.73 238929_at SFRS2B splicing factor, arginine/serine-rich 2B
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187 0.0002872 2.1 203317_at PSD4 pleckstrin and Sec7 domain containing 4
188 0.0002969 1.32 238263_at LOC285965 hypothetical protein LOC285965
189 0.0003005 2.64 235159_at NA NA
190 0.0003043 1.24 218388_at PGLS 6-phosphogluconolactonase
191 0.0003057 1.3 206729_at TNFRSF8 tumor necrosis factor receptor superfamily, member 8
192 0.0003121 1.28 231130_at NA NA
193 0.0003123 1.4 1552257_a_at TTLL12 tubulin tyrosine ligase-like family, member 12
194 0.0003129 1.29 219175_s_at SLC41A3 solute carrier family 41, member 3
195 0.0003162 1.41 204786_s_at IFNAR2 interferon (alpha, beta and omega) receptor 2
196 0.0003176 1.47 225391_at LOC93622 hypothetical LOC93622
197 0.0003216 1.35 227127_at TMEM110 transmembrane protein 110
198 0.0003219 3.64 202341_s_at TRIM2 tripartite motif-containing 2
199 0.0003243 2.09 210731_s_at LGALS8 lectin, galactoside-binding, soluble, 8
200 0.0003251 1.77 213374_x_at HIBCH 3-hydroxyisobutyryl-Coenzyme A hydrolase
201 0.0003260 1.38 200931_s_at VCL vinculin
202 0.0003264 1.45 230304_at NA NA
203 0.0003271 2.03 235195_at FBXW2 F-box and WD repeat domain containing 2
204 0.0003290 4.23 215726_s_at CYB5A cytochrome b5 type A (microsomal)
205 0.0003300 2.01 242794_at MAML3 mastermind-like 3 (Drosophila)
206 0.0003304 2.18 225961_at KLHDC5 kelch domain containing 5
207 0.0003309 1.48 212556_at SCRIB scribbled homolog (Drosophila)
208 0.0003322 2.66 220494_s_at NA NA
209 0.0003337 2.38 242297_at RREB1 ras responsive element binding protein 1
210 0.0003349 1.9 228771_at ADRBK2 adrenergic, beta, receptor kinase 2
211 0.0003390 1.19 227465_at KIAA0892 KIAA0892
212 0.0003390 1.37 228667_at AGPAT4 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid
acyltransferase, delta)
213 0.0003408 1.72 202161_at PKN1 protein kinase N1
214 0.0003417 1.32 AFFX-LysX-M_at NA NA
215 0.0003429 1.57 223314_at TSPAN14 tetraspanin 14
216 0.0003438 2.51 204610_s_at CCDC85B coiled-coil domain containing 85B
217 0.0003438 2.03 218027_at MRPL15 mitochondrial ribosomal protein L15
218 0.0003450 2.45 204718_at EPHB6 EPH receptor B6
219 0.0003454 2.06 227313_at CNPY4 canopy 4 homolog (zebrafish)
220 0.0003454 1.52 228600_x_at C7orf46 chromosome 7 open reading frame 46
221 0.0003472 1.28 226335_at RPS6KA3 ribosomal protein S6 kinase, 90kDa, polypeptide 3
222 0.0003481 1.48 219147_s_at C9orf95 chromosome 9 open reading frame 95
223 0.0003492 1.41 219801_at ZNF34 zinc finger protein 34
224 0.0003534 1.37 224865_at FAR1 fatty acyl CoA reductase 1
225 0.0003534 1.25 209450_at OSGEP O-sialoglycoprotein endopeptidase
226 0.0003535 1.8 239016_at NA NA
227 0.0003567 1.44 228670_at TEP1 telomerase-associated protein 1
228 0.0003600 1.87 210580_x_at SULT1A3 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
229 0.0003607 1.38 213945_s_at NUP210 nucleoporin 210kDa
230 0.0003644 1.32 218505_at WDR59 WD repeat domain 59
231 0.0003661 2.32 230343_at NA NA
232 0.0003663 2.08 230888_at WDR91 WD repeat domain 91
233 0.0003691 1.87 226368_at CHST11 carbohydrate (chondroitin 4) sulfotransferase 11
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234 0.0003691 1.67 213364_s_at SNX1 sorting nexin 1
235 0.0003706 2.17 213626_at CBR4 carbonyl reductase 4
236 0.0003712 1.45 AFFX-PheX-3_at NA NA
237 0.0003730 1.59 206567_s_at PHF20 PHD finger protein 20
238 0.0003737 1.49 221090_s_at OGFOD1 2-oxoglutarate and iron-dependent oxygenase domain containing 1
239 0.0003762 1.33 44040_at FBXO41 F-box protein 41
240 0.0003796 2.03 226238_at MCEE methylmalonyl CoA epimerase
241 0.0003812 1.45 204562_at IRF4 interferon regulatory factor 4
242 0.0003827 1.46 226241_s_at MRPL52 mitochondrial ribosomal protein L52
243 0.0003831 1.46 220178_at C19orf28 chromosome 19 open reading frame 28
244 0.0003841 1.31 209263_x_at TSPAN4 tetraspanin 4
245 0.0003893 1.45 232228_at ZNF530 zinc finger protein 530
246 0.0003907 2.04 208760_at UBE2I ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast)
247 0.0003909 1.18 224562_at WASF2 WAS protein family, member 2
248 0.0003923 1.63 213485_s_at ABCC10 ATP-binding cassette, sub-family C (CFTR/MRP), member 10
249 0.0003984 1.13 202942_at ETFB electron-transfer-flavoprotein, beta polypeptide
250 0.0004011 1.54 AFFX-LysX-3_at NA NA
251 0.0004028 1.79 212135_s_at ATP2B4 ATPase, Ca++ transporting, plasma membrane 4
252 0.0004062 1.24 217828_at SLTM SAFB-like, transcription modulator
253 0.0004150 2.05 212875_s_at C2CD2 C2 calcium-dependent domain containing 2
254 0.0004182 2.92 1557411_s_at SLC25A43 solute carrier family 25, member 43
255 0.0004259 2.11 227117_at NA NA
256 0.0004308 1.57 207124_s_at GNB5 guanine nucleotide binding protein (G protein), beta 5
257 0.0004325 1.6 227607_at STAMBPL1 STAM binding protein-like 1
258 0.0004326 1.25 204538_x_at NPIP nuclear pore complex interacting protein
259 0.0004339 2.03 244619_at BCL10 B-cell CLL/lymphoma 10
260 0.0004343 1.38 223239_at C14orf129 chromosome 14 open reading frame 129
261 0.0004347 1.58 201087_at PXN paxillin
262 0.0004367 1.8 219149_x_at DBR1 debranching enzyme homolog 1 (S. cerevisiae)
263 0.0004371 1.88 229905_at RAP1GDS1 RAP1, GTP-GDP dissociation stimulator 1
264 0.0004382 1.61 222111_at NA NA
265 0.0004389 2.71 235052_at ZNF792 zinc finger protein 792
266 0.0004422 1.62 225748_at LTV1 LTV1 homolog (S. cerevisiae)
267 0.0004451 1.37 241741_at CRLS1 cardiolipin synthase 1
268 0.0004463 1.46 221504_s_at ATP6V1H ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H
269 0.0004468 1.98 213448_at NA NA
270 0.0004483 1.15 201949_x_at CAPZB capping protein (actin filament) muscle Z-line, beta
271 0.0004501 2.15 234295_at DBR1 debranching enzyme homolog 1 (S. cerevisiae)
272 0.0004505 1.72 217608_at SFRS12IP1 SFRS12-interacting protein 1
273 0.0004518 1.34 215737_x_at USF2 upstream transcription factor 2, c-fos interacting
274 0.0004529 1.47 215873_x_at ABCC10 ATP-binding cassette, sub-family C (CFTR/MRP), member 10
275 0.0004530 2.34 1552256_a_at SCARB1 scavenger receptor class B, member 1
276 0.0004546 2.47 208657_s_at 9-Sep septin 9
277 0.0004555 2.08 228096_at C1orf151 chromosome 1 open reading frame 151
278 0.0004560 1.75 222471_s_at KCMF1 potassium channel modulatory factor 1
279 0.0004590 1.55 48808_at DHFR dihydrofolate reductase
280 0.0004608 3.5 227228_s_at CCDC88C coiled-coil domain containing 88C
281 0.0004636 1.94 1558445_at NA NA
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282 0.0004641 1.13 205540_s_at RRAGB Ras-related GTP binding B
283 0.0004670 1.48 227239_at FAM126A family with sequence similarity 126, member A
284 0.0004673 1.72 220246_at CAMK1D calcium/calmodulin-dependent protein kinase ID
285 0.0004677 3.38 226478_at NA NA
286 0.0004700 1.41 230235_at NA NA
287 0.0004709 1.22 220750_s_at LEPRE1 leucine proline-enriched proteoglycan (leprecan) 1
288 0.0004727 2.69 223455_at TCHP trichoplein, keratin filament binding
289 0.0004736 1.31 238552_at NA NA
290 0.0004739 1.47 200827_at PLOD1 procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1
291 0.0004751 1.28 227710_s_at NA NA
292 0.0004785 4.77 236798_at NA NA
293 0.0004788 1.88 242824_at NA NA
294 0.0004793 1.08 215846_at NA NA
295 0.0004795 1.92 211385_x_at SULT1A2 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
296 0.0004800 1.38 226358_at LOC145842 hypothetical protein LOC145842
297 0.0004832 1.95 213534_s_at PASK PAS domain containing serine/threonine kinase
298 0.0004841 5.65 205698_s_at MAP2K6 mitogen-activated protein kinase kinase 6
299 0.0004850 1.53 222661_at AGGF1 angiogenic factor with G patch and FHA domains 1
300 0.0004855 1.43 212036_s_at PNN pinin, desmosome associated protein
301 0.0004858 1.6 244534_at NA NA
302 0.0004876 1.58 1555751_a_at GEMIN7 gem (nuclear organelle) associated protein 7
303 0.0004879 1.87 203063_at PPM1F protein phosphatase 1F (PP2C domain containing)
304 0.0004973 1.16 205922_at VNN2 vanin 2
305 0.0004975 1.23 202797_at SACM1L SAC1 suppressor of actin mutations 1-like (yeast)
306 0.0005017 2.46 202826_at SPINT1 serine peptidase inhibitor, Kunitz type 1
307 0.0005059 1.73 226073_at TMEM218 transmembrane protein 218
308 0.0005077 1.55 238523_at KLHL36 kelch-like 36 (Drosophila)
309 0.0005080 1.78 231843_at DDX55 DEAD (Asp-Glu-Ala-Asp) box polypeptide 55
310 0.0005094 2.26 219714_s_at CACNA2D3 calcium channel, voltage-dependent, alpha 2/delta subunit 3
311 0.0005097 2.02 229202_at NA NA
312 0.0005114 3.54 209048_s_at ZMYND8 zinc finger, MYND-type containing 8
313 0.0005132 1.64 218473_s_at GLT25D1 glycosyltransferase 25 domain containing 1
314 0.0005172 1.71 65493_at HEATR6 HEAT repeat containing 6
315 0.0005179 2.03 236194_at NA NA
316 0.0005179 2.28 226531_at ORAI1 ORAI calcium release-activated calcium modulator 1
317 0.0005201 1.58 219351_at TRAPPC2 trafficking protein particle complex 2
318 0.0005244 1.26 220036_s_at LMBR1L limb region 1 homolog (mouse)-like
319 0.0005321 4.22 217974_at TM7SF3 transmembrane 7 superfamily member 3
320 0.0005335 1.26 211759_x_at TBCB tubulin folding cofactor B
321 0.0005359 1.4 242155_x_at NA NA
322 0.0005397 2 209377_s_at HMGN3 high mobility group nucleosomal binding domain 3
323 0.0005401 2.12 230653_at LOC100132218 hypothetical protein LOC100132218
324 0.0005504 1.77 224708_at KIAA2013 KIAA2013
325 0.0005504 1.9 204000_at GNB5 guanine nucleotide binding protein (G protein), beta 5
326 0.0005559 1.32 244346_at NA NA
327 0.0005568 1.9 225108_at AGPS alkylglycerone phosphate synthase
328 0.0005599 1.85 236626_at NA NA
329 0.0005615 1.85 228314_at LRRC8C leucine rich repeat containing 8 family, member C
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330 0.0005636 1.46 1558754_at ZNF763 zinc finger protein 763
331 0.0005650 1.42 226155_at FAM160B1 family with sequence similarity 160, member B1
332 0.0005679 1.72 229705_at NA NA
333 0.0005686 4.21 228891_at C9orf164 chromosome 9 open reading frame 164
334 0.0005708 1.49 225146_at C9orf25 chromosome 9 open reading frame 25
335 0.0005724 1.86 219817_at C12orf47 chromosome 12 open reading frame 47
336 0.0005724 1.58 235610_at ALKBH8 alkB, alkylation repair homolog 8 (E. coli)
337 0.0005728 1.59 217949_s_at VKORC1 vitamin K epoxide reductase complex, subunit 1
338 0.0005746 2.14 222858_s_at DAPP1 dual adaptor of phosphotyrosine and 3-phosphoinositides
339 0.0005748 1.17 223049_at GRB2 growth factor receptor-bound protein 2
340 0.0005792 1.45 212987_at FBXO9 F-box protein 9
341 0.0005793 1.42 209903_s_at ATR ataxia telangiectasia and Rad3 related
342 0.0005805 1.45 201067_at PSMC2 proteasome (prosome, macropain) 26S subunit, ATPase, 2
343 0.0005806 1.37 201076_at NHP2L1 NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)
344 0.0005811 1.28 236804_at NA NA
345 0.0005820 1.27 234107_s_at DTD1 D-tyrosyl-tRNA deacylase 1 homolog (S. cerevisiae)
346 0.0005858 2.04 1553987_at C12orf47 chromosome 12 open reading frame 47
347 0.0005877 1.42 226679_at SLC26A11 solute carrier family 26, member 11
348 0.0005893 1.7 1554608_at TGOLN2 trans-golgi network protein 2
349 0.0005911 1.65 219256_s_at SH3TC1 SH3 domain and tetratricopeptide repeats 1
350 0.0005950 1.46 232369_at NA NA
351 0.0005992 1.39 243750_x_at C21orf70 chromosome 21 open reading frame 70
352 0.0006007 2.4 219759_at ERAP2 endoplasmic reticulum aminopeptidase 2
353 0.0006025 1.24 203981_s_at ABCD4 ATP-binding cassette, sub-family D (ALD), member 4
354 0.0006028 1.43 202428_x_at DBI diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A
binding protein)
355 0.0006039 1.54 212886_at CCDC69 coiled-coil domain containing 69
356 0.0006041 2.12 221878_at C2orf68 chromosome 2 open reading frame 68
357 0.0006052 1.91 202039_at TIAF1 TGFB1-induced anti-apoptotic factor 1
358 0.0006058 2.8 40472_at LPCAT4 lysophosphatidylcholine acyltransferase 4
359 0.0006135 1.48 217751_at GSTK1 glutathione S-transferase kappa 1
360 0.0006135 1.84 228303_at GALNT6 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 6 (GalNAc-T6)
361 0.0006147 1.44 202172_at VEZF1 vascular endothelial zinc finger 1
362 0.0006167 2.09 1558692_at C1orf85 chromosome 1 open reading frame 85
363 0.0006190 1.89 207122_x_at SULT1A2 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
364 0.0006205 1.49 1560874_at FLJ33046 hypothetical gene supported by AK057608
365 0.0006228 1.97 212473_s_at MICAL2 microtubule associated monoxygenase, calponin and LIM domain
containing 2
366 0.0006241 1.67 225409_at C2orf64 chromosome 2 open reading frame 64
367 0.0006246 1.97 203615_x_at SULT1A1 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
368 0.0006275 1.4 224724_at SULF2 sulfatase 2
369 0.0006277 1.47 225022_at GOPC golgi associated PDZ and coiled-coil motif containing
370 0.0006282 1.18 214879_x_at USF2 upstream transcription factor 2, c-fos interacting
371 0.0006311 1.43 222843_at FIGNL1 fidgetin-like 1
372 0.0006313 2.06 210136_at MBP myelin basic protein
373 0.0006322 2.27 229512_at FAM120C family with sequence similarity 120C
374 0.0006326 1.2 209017_s_at LONP1 lon peptidase 1, mitochondrial
375 0.0006333 1.69 237926_s_at NA NA
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376 0.0006351 1.44 222294_s_at RAB27A RAB27A, member RAS oncogene family
377 0.0006411 3.49 210986_s_at TPM1 tropomyosin 1 (alpha)
378 0.0006490 1.28 209932_s_at DUT deoxyuridine triphosphatase
379 0.0006513 1.28 227656_at C6orf70 chromosome 6 open reading frame 70
380 0.0006514 1.63 228131_at ERCC1 excision repair cross-complementing rodent repair deficiency,
complementation group 1 (includes overlapping antisense sequence)
381 0.0006519 1.11 212848_s_at C9orf3 chromosome 9 open reading frame 3
382 0.0006526 2.3 1552540_s_at IQCD IQ motif containing D
383 0.0006530 2.09 239698_at NA NA
384 0.0006586 1.62 1553102_a_at CCDC69 coiled-coil domain containing 69
385 0.0006622 1.77 228542_at MRS2 MRS2 magnesium homeostasis factor homolog (S. cerevisiae)
386 0.0006623 1.37 208956_x_at DUT deoxyuridine triphosphatase
387 0.0006635 2.14 223528_s_at METT11D1 methyltransferase 11 domain containing 1
388 0.0006636 1.38 201234_at ILK integrin-linked kinase
389 0.0006637 1.57 228694_at NA NA
390 0.0006659 1.36 225136_at PLEKHA2 pleckstrin homology domain containing, family A (phosphoinositide
binding specific) member 2
391 0.0006723 1.55 212567_s_at MAP4 microtubule-associated protein 4
392 0.0006726 1.52 219549_s_at RTN3 reticulon 3
393 0.0006730 1.89 232681_at NA NA
394 0.0006742 2.21 219627_at ZNF767 zinc finger family member 767
395 0.0006762 2.7 231449_at NA NA
396 0.0006771 1.58 239035_at MTHFR 5,10-methylenetetrahydrofolate reductase (NADPH)
397 0.0006773 1.39 205256_at ZBTB39 zinc finger and BTB domain containing 39
398 0.0006786 1.51 205945_at IL6R interleukin 6 receptor
399 0.0006802 4.26 230032_at OSGEPL1 O-sialoglycoprotein endopeptidase-like 1
400 0.0006837 1.56 225888_at C12orf30 chromosome 12 open reading frame 30
401 0.0006840 1.35 227767_at CSNK1G3 casein kinase 1, gamma 3
402 0.0006879 1.76 205060_at PARG poly (ADP-ribose) glycohydrolase
403 0.0006921 1.37 239730_at DGCR14 DiGeorge syndrome critical region gene 14
404 0.0006924 1.58 201029_s_at CD99 CD99 molecule
405 0.0006928 1.63 211709_s_at CLEC11A C-type lectin domain family 11, member A
406 0.0006952 1.95 201985_at KIAA0196 KIAA0196
407 0.0006964 2.17 204995_at CDK5R1 cyclin-dependent kinase 5, regulatory subunit 1 (p35)
408 0.0007029 1.52 217521_at NA NA
409 0.0007045 1.35 1558184_s_at ZNF17 zinc finger protein 17
410 0.0007099 1.24 218167_at AMZ2 archaelysin family metallopeptidase 2
411 0.0007119 1.52 226712_at SSR1 signal sequence receptor, alpha
412 0.0007129 1.22 238668_at NA NA
413 0.0007138 1.16 221651_x_at IGKC immunoglobulin kappa constant
414 0.0007143 1.85 64064_at GIMAP5 GTPase, IMAP family member 5
415 0.0007160 1.24 234734_s_at TNRC6A trinucleotide repeat containing 6A
416 0.0007165 1.34 213582_at ATP11A ATPase, class VI, type 11A
417 0.0007176 1.34 226165_at C8orf59 chromosome 8 open reading frame 59
418 0.0007186 2.61 205565_s_at FXN frataxin
419 0.0007225 1.21 220251_at C1orf107 chromosome 1 open reading frame 107
420 0.0007231 2.16 225980_at C14orf43 chromosome 14 open reading frame 43
421 0.0007247 1.69 238379_x_at NA NA
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422 0.0007266 1.72 1559034_at SIRPB2 signal-regulatory protein beta 2
423 0.0007273 1.21 201053_s_at PSMF1 proteasome (prosome, macropain) inhibitor subunit 1 (PI31)
424 0.0007318 1.1 40225_at GAK cyclin G associated kinase
425 0.0007329 2.14 209729_at GAS2L1 growth arrest-specific 2 like 1
426 0.0007344 1.55 221027_s_at PLA2G12A phospholipase A2, group XIIA
427 0.0007348 1.28 209724_s_at ZFP161 zinc finger protein 161 homolog (mouse)
428 0.0007380 1.4 214494_s_at SPG7 spastic paraplegia 7 (pure and complicated autosomal recessive)
429 0.0007392 1.58 205131_x_at CLEC11A C-type lectin domain family 11, member A
430 0.0007393 2.07 204019_s_at SH3YL1 SH3 domain containing, Ysc84-like 1 (S. cerevisiae)
431 0.0007417 1.42 214861_at JMJD2C jumonji domain containing 2C
432 0.0007421 1.69 242965_at NA NA
433 0.0007485 1.99 228167_at KLHL6 kelch-like 6 (Drosophila)
434 0.0007547 2.15 209269_s_at SYK spleen tyrosine kinase
435 0.0007563 1.5 244663_at NA NA
436 0.0007563 2.14 203802_x_at NSUN5 NOL1/NOP2/Sun domain family, member 5
437 0.0007578 1.62 242108_at NA NA
438 0.0007655 1.46 205632_s_at PIP5K1B phosphatidylinositol-4-phosphate 5-kinase, type I, beta
439 0.0007691 2.28 238604_at NA NA
440 0.0007694 1.25 219084_at NSD1 nuclear receptor binding SET domain protein 1
441 0.0007712 1.4 223716_s_at ZRANB2 zinc finger, RAN-binding domain containing 2
442 0.0007728 1.82 209760_at KIAA0922 KIAA0922
443 0.0007796 1.29 214437_s_at SHMT2 serine hydroxymethyltransferase 2 (mitochondrial)
444 0.0007836 1.46 224704_at TNRC6A trinucleotide repeat containing 6A
445 0.0007841 2.01 223339_at ATPIF1 ATPase inhibitory factor 1
446 0.0007848 1.59 222622_at PGP phosphoglycolate phosphatase
447 0.0007851 1.62 218231_at NAGK N-acetylglucosamine kinase
448 0.0007878 1.79 1554544_a_at MBP myelin basic protein
449 0.0007894 2.2 1554250_s_at TRIM73 tripartite motif-containing 73
450 0.0007896 2.19 216199_s_at MAP3K4 mitogen-activated protein kinase kinase kinase 4
451 0.0007925 1.3 206881_s_at LILRA3 leukocyte immunoglobulin-like receptor, subfamily A (without TM
domain), member 3
452 0.0007976 1.65 226716_at PRR12 proline rich 12
453 0.0007989 1.67 202534_x_at DHFR dihydrofolate reductase
454 0.0007995 2.43 202369_s_at TRAM2 translocation associated membrane protein 2
455 0.0008009 2.59 218112_at MRPS34 mitochondrial ribosomal protein S34
456 0.0008035 1.48 230925_at APBB1IP amyloid beta (A4) precursor protein-binding, family B, member 1
interacting protein
457 0.0008086 1.16 213027_at TROVE2 TROVE domain family, member 2
458 0.0008124 2.99 1562289_at NA NA
459 0.0008148 1.41 202615_at GNAQ guanine nucleotide binding protein (G protein), q polypeptide
460 0.0008150 1.71 219151_s_at RABL2B RAB, member of RAS oncogene family-like 2B
461 0.0008158 2.1 1559214_at NA NA
462 0.0008161 1.84 203711_s_at HIBCH 3-hydroxyisobutyryl-Coenzyme A hydrolase
463 0.0008187 1.87 233955_x_at CXXC5 CXXC finger 5
464 0.0008205 1.26 201804_x_at TBCB tubulin folding cofactor B
465 0.0008207 1.44 211100_x_at LILRA2 leukocyte immunoglobulin-like receptor, subfamily A (with TM domain),
member 2
466 0.0008229 5.13 212757_s_at CAMK2G calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma
467 0.0008232 1.76 214202_at NA NA
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468 0.0008255 2.01 221746_at UBL4A ubiquitin-like 4A
469 0.0008277 1.35 1560587_s_at PRDX5 peroxiredoxin 5
470 0.0008278 1.41 211070_x_at DBI diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A
binding protein)
471 0.0008279 1.53 242887_at KCMF1 potassium channel modulatory factor 1
472 0.0008283 1.29 206200_s_at ANXA11 annexin A11
473 0.0008318 1.72 203607_at INPP5F inositol polyphosphate-5-phosphatase F
474 0.0008344 1.9 205282_at LRP8 low density lipoprotein receptor-related protein 8, apolipoprotein e
receptor
475 0.0008347 1.42 209566_at INSIG2 insulin induced gene 2
476 0.0008361 1.54 223306_at EBPL emopamil binding protein-like
477 0.0008444 3.9 210166_at TLR5 toll-like receptor 5
478 0.0008451 1.44 225050_at ZNF512 zinc finger protein 512
479 0.0008463 1.9 226480_at NA NA
480 0.0008510 1.22 211152_s_at HTRA2 HtrA serine peptidase 2
481 0.0008526 1.9 222603_at ERMP1 endoplasmic reticulum metallopeptidase 1
482 0.0008590 1.42 226078_at RPUSD1 RNA pseudouridylate synthase domain containing 1
483 0.0008602 1.89 203409_at DDB2 damage-specific DNA binding protein 2, 48kDa
484 0.0008607 1.79 222996_s_at CXXC5 CXXC finger 5
485 0.0008619 1.42 229597_s_at WDFY4 WDFY family member 4
486 0.0008625 1.21 209420_s_at SMPD1 sphingomyelin phosphodiesterase 1, acid lysosomal
487 0.0008648 2.16 213333_at MDH2 malate dehydrogenase 2, NAD (mitochondrial)
488 0.0008654 1.57 232524_x_at ANAPC4 anaphase promoting complex subunit 4
489 0.0008674 1.63 238058_at FLJ27365 FLJ27365 protein
490 0.0008682 2.88 212660_at PHF15 PHD finger protein 15
491 0.0008701 2.47 209197_at SYT11 synaptotagmin XI
492 0.0008755 1.49 200875_s_at NOL5A nucleolar protein 5A (56kDa with KKE/D repeat)
493 0.0008868 5.04 207008_at IL8RB interleukin 8 receptor, beta
494 0.0008925 1.33 233694_at HSPA1L heat shock 70kDa protein 1-like
495 0.0008958 1.35 217957_at C16orf80 chromosome 16 open reading frame 80
496 0.0008961 1.64 228070_at PPP2R5E protein phosphatase 2, regulatory subunit B@#$%&, epsilon isoform
497 0.0008967 1.56 225997_at MOBKL1A MOB1, Mps One Binder kinase activator-like 1A (yeast)
498 0.0009020 1.98 65438_at KIAA1609 KIAA1609
499 0.0009056 1.82 218921_at SIGIRR single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
500 0.0009103 1.06 240001_at NA NA
501 0.0009114 1.51 227533_at NA NA
502 0.0009136 1.47 226333_at IL6R interleukin 6 receptor
503 0.0009154 1.68 1562249_at LOC285965 hypothetical protein LOC285965
504 0.0009189 3.86 204301_at KBTBD11 kelch repeat and BTB (POZ) domain containing 11
505 0.0009197 1.67 213296_at RER1 RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae)
506 0.0009228 1.32 224688_at C7orf42 chromosome 7 open reading frame 42
507 0.0009245 1.91 221843_s_at KIAA1609 KIAA1609
508 0.0009272 1.24 1569808_at NA NA
509 0.0009308 5.94 38290_at RGS14 regulator of G-protein signaling 14
510 0.0009357 3.85 226820_at ZNF362 zinc finger protein 362
511 0.0009370 1.35 241344_at NA NA
512 0.0009378 1.73 228512_at PTCD3 Pentatricopeptide repeat domain 3
513 0.0009417 1.63 210830_s_at PON2 paraoxonase 2
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514 0.0009436 1.44 219493_at SHCBP1 SHC SH2-domain binding protein 1
515 0.0009471 1.38 230122_at MLLT10 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog,
Drosophila); translocated to, 10
516 0.0009526 1.67 218380_at NLRP1 NLR family, pyrin domain containing 1
517 0.0009562 1.42 202200_s_at SRPK1 SFRS protein kinase 1
518 0.0009575 1.63 202741_at PRKACB protein kinase, cAMP-dependent, catalytic, beta
519 0.0009592 1.43 228869_at NA NA
520 0.0009614 1.25 224252_s_at FXYD5 FXYD domain containing ion transport regulator 5
521 0.0009626 1.45 221488_s_at CUTA cutA divalent cation tolerance homolog (E. coli)
522 0.0009634 1.7 244687_at DBT dihydrolipoamide branched chain transacylase E2
523 0.0009679 1.17 209445_x_at C7orf44 chromosome 7 open reading frame 44
524 0.0009703 1.14 244537_at NA NA
525 0.0009717 1.7 226104_at RNF170 ring finger protein 170
526 0.0009730 1.31 205240_at GPSM2 G-protein signaling modulator 2 (AGS3-like, C. elegans)
527 0.0009732 1.73 200766_at CTSD cathepsin D
528 0.0009734 1.41 231844_at MGC27345 hypothetical protein MGC27345
529 0.0009738 1.29 202634_at POLR2K polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa
530 0.0009760 1.58 224938_at NUFIP2 nuclear fragile X mental retardation protein interacting protein 2
531 0.0009764 2.26 204089_x_at MAP3K4 mitogen-activated protein kinase kinase kinase 4
532 0.0009776 1.93 211985_s_at CALM1 calmodulin 1 (phosphorylase kinase, delta)
533 0.0009778 2.65 213280_at GARNL4 GTPase activating Rap/RanGAP domain-like 4
534 0.0009805 1.48 236016_at NA NA
535 0.0009828 1.84 217394_at NA NA
536 0.0009900 1.58 201030_x_at LDHB lactate dehydrogenase B
537 0.0009925 1.81 227379_at MBOAT1 membrane bound O-acyltransferase domain containing 1
538 0.0009997 -1.19 236663_at NA NA
539 0.0009983 -1.6 219766_at B9D2 B9 protein domain 2
540 0.0009949 -1.71 204157_s_at KIAA0999 KIAA0999 protein
541 0.0009891 -1.23 214060_at SSBP1 single-stranded DNA binding protein 1
542 0.0009868 -1.47 226276_at TMEM167A transmembrane protein 167A
543 0.0009825 -1.75 203596_s_at IFIT5 interferon-induced protein with tetratricopeptide repeats 5
544 0.0009805 -1.64 226310_at RICTOR rapamycin-insensitive companion of mTOR
545 0.0009772 -2.29 218986_s_at DDX60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60
546 0.0009758 -1.52 217618_x_at HUS1 HUS1 checkpoint homolog (S. pombe)
547 0.0009746 -2.4 219017_at ETNK1 ethanolamine kinase 1
548 0.0009745 -1.24 201957_at PPP1R12B protein phosphatase 1, regulatory (inhibitor) subunit 12B
549 0.0009737 -1.26 240887_at NA NA
550 0.0009681 -1.33 209514_s_at RAB27A RAB27A, member RAS oncogene family
551 0.0009661 -2.54 219026_s_at RASAL2 RAS protein activator like 2
552 0.0009592 -1.49 211395_x_at FCGR2C Fc fragment of IgG, low affinity IIc, receptor for (CD32)
553 0.0009568 -3.72 205126_at VRK2 vaccinia related kinase 2
554 0.0009560 -1.22 1556514_at LOC338809 hypothetical protein LOC338809
555 0.0009506 -2.66 206991_s_at CCR5 chemokine (C-C motif) receptor 5
556 0.0009500 -1.47 212840_at UBXN7 UBX domain protein 7
557 0.0009443 -1.25 244496_at NA NA
558 0.0009406 -1.21 236108_at KIAA1632 KIAA1632
559 0.0009366 -1.2 203654_s_at COIL coilin
560 0.0009338 -2.95 236156_at LIPA lipase A, lysosomal acid, cholesterol esterase
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561 0.0009309 -1.3 212462_at MYST4 MYST histone acetyltransferase (monocytic leukemia) 4
562 0.0009278 -2.58 219403_s_at HPSE heparanase
563 0.0009220 -1.58 1554747_a_at 2-Sep septin 2
564 0.0009134 -1.08 203291_at CNOT4 CCR4-NOT transcription complex, subunit 4
565 0.0009077 -1.25 243772_at SDCCAG8 serologically defined colon cancer antigen 8
566 0.0009071 -1.7 201656_at ITGA6 integrin, alpha 6
567 0.0009063 -3.06 201325_s_at EMP1 epithelial membrane protein 1
568 0.0009031 -1.27 209531_at GSTZ1 glutathione transferase zeta 1
569 0.0008974 -1.42 208779_x_at DDR1 discoidin domain receptor tyrosine kinase 1
570 0.0008959 -1.19 242654_at FANCC Fanconi anemia, complementation group C
571 0.0008945 -1.16 220386_s_at EML4 echinoderm microtubule associated protein like 4
572 0.0008922 -1.32 227003_at RAB28 RAB28, member RAS oncogene family
573 0.0008910 -3.14 224009_x_at DHRS9 dehydrogenase/reductase (SDR family) member 9
574 0.0008877 -1.67 32069_at N4BP1 NEDD4 binding protein 1
575 0.0008870 -1.29 232141_at U2AF1 U2 small nuclear RNA auxiliary factor 1
576 0.0008761 -1.35 240468_at NA NA
577 0.0008698 -1.32 204367_at SP2 Sp2 transcription factor
578 0.0008616 -1.87 225076_s_at ZNFX1 zinc finger, NFX1-type containing 1
579 0.0008599 -1.25 225056_at SIPA1L2 signal-induced proliferation-associated 1 like 2
580 0.0008580 -1.13 207070_at RGR retinal G protein coupled receptor
581 0.0008574 -1.28 217129_at NA NA
582 0.0008537 -1.22 225268_at KPNA4 karyopherin alpha 4 (importin alpha 3)
583 0.0008463 -1.07 232295_at GFM1 G elongation factor, mitochondrial 1
584 0.0008408 -1.33 211975_at ARFGAP2 ADP-ribosylation factor GTPase activating protein 2
585 0.0008385 -1.24 244625_at NA NA
586 0.0008384 -1.49 202083_s_at SEC14L1 SEC14-like 1 (S. cerevisiae)
587 0.0008274 -1.34 232987_at ARL17 ADP-ribosylation factor-like 17
588 0.0008198 -1.33 1570541_s_at NA NA
589 0.0008196 -2.91 201324_at EMP1 epithelial membrane protein 1
590 0.0008172 -1.42 222408_s_at YPEL5 yippee-like 5 (Drosophila)
591 0.0008164 -1.3 201585_s_at SFPQ splicing factor proline/glutamine-rich (polypyrimidine tract binding protein
associated)
592 0.0008160 -1.35 243492_at THEM4 thioesterase superfamily member 4
593 0.0008023 -1.53 222537_s_at CDC42SE1 CDC42 small effector 1
594 0.0007993 -1.38 223225_s_at SEH1L SEH1-like (S. cerevisiae)
595 0.0007951 -1.4 231139_at NA NA
596 0.0007921 -3.08 206911_at TRIM25 tripartite motif-containing 25
597 0.0007824 -1.55 1554390_s_at ACTR2 ARP2 actin-related protein 2 homolog (yeast)
598 0.0007777 -1.32 208824_x_at PCTK1 PCTAIRE protein kinase 1
599 0.0007732 -1.36 214258_x_at KAT5 K(lysine) acetyltransferase 5
600 0.0007729 -1.47 208751_at NAPA N-ethylmaleimide-sensitive factor attachment protein, alpha
601 0.0007690 -1.16 238337_s_at DNAJC21 DnaJ (Hsp40) homolog, subfamily C, member 21
602 0.0007673 -1.31 211314_at CACNA1G calcium channel, voltage-dependent, T type, alpha 1G subunit
603 0.0007657 -1.53 217834_s_at SYNCRIP synaptotagmin binding, cytoplasmic RNA interacting protein
604 0.0007625 -1.85 208653_s_at CD164 CD164 molecule, sialomucin
605 0.0007608 -1.45 209091_s_at SH3GLB1 SH3-domain GRB2-like endophilin B1
606 0.0007426 -1.25 1557533_at NA NA
607 0.0007405 -2.01 1555785_a_at XRN1 5@#$%&-3@#$%& exoribonuclease 1
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608 0.0007371 -1.41 236961_at NA NA
609 0.0007346 -1.14 204080_at TOE1 target of EGR1, member 1 (nuclear)
610 0.0007341 -1.29 243852_at LUC7L2 LUC7-like 2 (S. cerevisiae)
611 0.0007227 -1.29 210317_s_at YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, epsilon polypeptide
612 0.0007183 -1.4 209284_s_at C3orf63 chromosome 3 open reading frame 63
613 0.0007169 -3.19 227361_at HS3ST3B1 heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1
614 0.0007139 -1.19 211066_x_at PCDHGC3 protocadherin gamma subfamily C, 3
615 0.0006984 -1.09 202814_s_at HEXIM1 hexamethylene bis-acetamide inducible 1
616 0.0006943 -1.35 226710_at C8orf82 chromosome 8 open reading frame 82
617 0.0006932 -3.2 209969_s_at STAT1 signal transducer and activator of transcription 1, 91kDa
618 0.0006882 -1.56 225242_s_at CCDC80 coiled-coil domain containing 80
619 0.0006875 -1.5 214121_x_at PDLIM7 PDZ and LIM domain 7 (enigma)
620 0.0006868 -1.41 203916_at NDST2 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2
621 0.0006826 -1.32 208901_s_at TOP1 topoisomerase (DNA) I
622 0.0006769 -2.95 206028_s_at MERTK c-mer proto-oncogene tyrosine kinase
623 0.0006749 -1.35 205724_at PKP1 plakophilin 1 (ectodermal dysplasia/skin fragility syndrome)
624 0.0006737 -1.23 228121_at NA NA
625 0.0006701 -1.04 226928_x_at SLC25A37 solute carrier family 25, member 37
626 0.0006700 -1.37 1555301_a_at DIP2A DIP2 disco-interacting protein 2 homolog A (Drosophila)
627 0.0006616 -1.27 1566301_at PPP1R11 protein phosphatase 1, regulatory (inhibitor) subunit 11
628 0.0006570 -1.46 234519_at NOBOX NOBOX oogenesis homeobox
629 0.0006553 -1.24 218520_at TBK1 TANK-binding kinase 1
630 0.0006552 -1.55 201878_at ARIH1 ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1
(Drosophila)
631 0.0006495 -1.3 1564131_a_at NA NA
632 0.0006472 -1.49 209102_s_at HBP1 HMG-box transcription factor 1
633 0.0006450 -1.18 238586_at LOC731489 hypothetical protein LOC731489
634 0.0006425 -1.03 216231_s_at B2M beta-2-microglobulin
635 0.0006398 -1.79 1552772_at CLEC4D C-type lectin domain family 4, member D
636 0.0006384 -1.42 201586_s_at SFPQ splicing factor proline/glutamine-rich (polypyrimidine tract binding protein
associated)
637 0.0006373 -1.74 41644_at SASH1 SAM and SH3 domain containing 1
638 0.0006346 -1.11 216652_s_at DR1 down-regulator of transcription 1, TBP-binding (negative cofactor 2)
639 0.0006313 -1.3 212436_at TRIM33 tripartite motif-containing 33
640 0.0006284 -1.57 212264_s_at WAPAL wings apart-like homolog (Drosophila)
641 0.0006259 -1.2 226481_at VPRBP Vpr (HIV-1) binding protein
642 0.0006104 -1.35 217490_at NA NA
643 0.0006091 -1.29 1557463_at NA NA
644 0.0005929 -1.35 238273_at PL-5283 PL-5283 protein
645 0.0005927 -1.77 203840_at BLZF1 basic leucine zipper nuclear factor 1
646 0.0005896 -1.17 237604_at LOC415056 hypothetical gene LOC415056
647 0.0005883 -1.9 222881_at HPSE heparanase
648 0.0005855 -1.25 220634_at TBX4 T-box 4
649 0.0005853 -1.3 200669_s_at UBE2D3 ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast)
650 0.0005801 -1.05 232017_at TJP2 tight junction protein 2 (zona occludens 2)
651 0.0005772 -1.35 213918_s_at NIPBL Nipped-B homolog (Drosophila)
652 0.0005770 -1.62 215357_s_at POLDIP3 polymerase (DNA-directed), delta interacting protein 3
653 0.0005750 -1.4 1561354_at NA NA
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654 0.0005678 -1.08 206516_at AMH anti-Mullerian hormone
655 0.0005652 -2.05 211030_s_at SLC6A6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6
656 0.0005634 -2.18 222651_s_at TRPS1 trichorhinophalangeal syndrome I
657 0.0005618 -2.05 57703_at SENP5 SUMO1/sentrin specific peptidase 5
658 0.0005604 -11.89 211372_s_at IL1R2 interleukin 1 receptor, type II
659 0.0005547 -1.2 1567246_at OR5H1 olfactory receptor, family 5, subfamily H, member 1
660 0.0005488 -1.85 205003_at DOCK4 dedicator of cytokinesis 4
661 0.0005371 -2.37 222262_s_at ETNK1 ethanolamine kinase 1
662 0.0005358 -1.38 201684_s_at TOX4 TOX high mobility group box family member 4
663 0.0005357 -1.85 206011_at CASP1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta,
convertase)
664 0.0005349 -1.16 211505_s_at STAU1 staufen, RNA binding protein, homolog 1 (Drosophila)
665 0.0005342 -1.47 1554049_s_at WDR42A WD repeat domain 42A
666 0.0005321 -1.36 225978_at FAM80B family with sequence similarity 80, member B
667 0.0005228 -1.15 215056_at NA NA
668 0.0005162 -1.38 202066_at PPFIA1 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
interacting protein (liprin), alpha 1
669 0.0005087 -1.13 226128_at NA NA
670 0.0005005 -1.17 1562449_s_at NA NA
671 0.0004997 -1.51 217847_s_at THRAP3 thyroid hormone receptor associated protein 3
672 0.0004992 -1.6 229845_at MAPKAP1 mitogen-activated protein kinase associated protein 1
673 0.0004955 -2.82 211806_s_at KCNJ15 potassium inwardly-rectifying channel, subfamily J, member 15
674 0.0004947 -2.32 217503_at NA NA
675 0.0004946 -1.2 221147_x_at WWOX WW domain containing oxidoreductase
676 0.0004897 -1.26 1552684_a_at SENP8 SUMO/sentrin specific peptidase family member 8
677 0.0004707 -1.17 206251_s_at AVPR1A arginine vasopressin receptor 1A
678 0.0004609 -1.24 223546_x_at LUC7L LUC7-like (S. cerevisiae)
679 0.0004595 -1.33 208576_s_at HIST1H3B histone cluster 1, H3b
680 0.0004582 -1.97 202684_s_at RNMT RNA (guanine-7-) methyltransferase
681 0.0004567 -1.36 201378_s_at UBAP2L ubiquitin associated protein 2-like
682 0.0004553 -1.15 202178_at PRKCZ protein kinase C, zeta
683 0.0004545 -1.13 1555139_a_at OTUD7B OTU domain containing 7B
684 0.0004543 -1.47 244595_at NA NA
685 0.0004511 -1.32 210592_s_at 04/01/12 spermidine/spermine N1-acetyltransferase 1
686 0.0004444 -1.21 1554327_a_at CANT1 calcium activated nucleotidase 1
687 0.0004435 -1.41 223430_at SNF1LK2 SNF1-like kinase 2
688 0.0004430 -1.42 232437_at CPSF3L cleavage and polyadenylation specific factor 3-like
689 0.0004418 -1.11 202230_s_at CHERP calcium homeostasis endoplasmic reticulum protein
690 0.0004358 -1.8 211782_at IDS iduronate 2-sulfatase
691 0.0004288 -1.63 208869_s_at GABARAPL1 GABA(A) receptor-associated protein like 1
692 0.0004258 -1.14 1554646_at OSBPL1A oxysterol binding protein-like 1A
693 0.0004189 -1.29 224410_s_at LMBR1 limb region 1 homolog (mouse)
694 0.0004130 -1.09 201698_s_at SFRS9 splicing factor, arginine/serine-rich 9
695 0.0004109 -1.57 218578_at CDC73 cell division cycle 73, Paf1/RNA polymerase II complex component,
homolog (S. cerevisiae)
696 0.0003904 -1.3 1566456_at NA NA
697 0.0003884 -2.78 226026_at DIRC2 disrupted in renal carcinoma 2
698 0.0003884 -1.49 222035_s_at PAPOLA poly(A) polymerase alpha
699 0.0003882 -1.25 240313_at DMRTB1 DMRT-like family B with proline-rich C-terminal, 1
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700 0.0003880 -1.65 242943_at ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
701 0.0003868 -2.87 243271_at NA NA
702 0.0003850 -1.43 234173_s_at NXF2 nuclear RNA export factor 2
703 0.0003839 -1.93 211368_s_at CASP1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta,
convertase)
704 0.0003823 -1.24 227712_at LYRM2 LYR motif containing 2
705 0.0003803 -1.63 201377_at UBAP2L ubiquitin associated protein 2-like
706 0.0003785 -1.4 204858_s_at TYMP thymidine phosphorylase
707 0.0003695 -1.53 205415_s_at ATXN3 ataxin 3
708 0.0003684 -2.46 209237_s_at SLC23A2 solute carrier family 23 (nucleobase transporters), member 2
709 0.0003661 -1.25 235833_at PPAT phosphoribosyl pyrophosphate amidotransferase
710 0.0003575 -1.29 209590_at BMP7 bone morphogenetic protein 7
711 0.0003529 -3.5 215966_x_at GK3P glycerol kinase 3 pseudogene
712 0.0003527 -1.22 202807_s_at TOM1 target of myb1 (chicken)
713 0.0003455 -1.18 201198_s_at PSMD1 proteasome (prosome, macropain) 26S subunit, non-ATPase, 1
714 0.0003409 -3.97 202068_s_at LDLR low density lipoprotein receptor
715 0.0003389 -1.07 200914_x_at KTN1 kinectin 1 (kinesin receptor)
716 0.0003355 -1.77 225395_s_at FAM120AOS family with sequence similarity 120A opposite strand
717 0.0003300 -1.17 216306_x_at PTBP1 polypyrimidine tract binding protein 1
718 0.0003300 -1.38 208985_s_at EIF3J eukaryotic translation initiation factor 3, subunit J
719 0.0003231 -1.15 1569932_at NHSL2 NHS-like 2
720 0.0003229 -1.41 204781_s_at FAS Fas (TNF receptor superfamily, member 6)
721 0.0003210 -2 209593_s_at TOR1B torsin family 1, member B (torsin B)
722 0.0003206 -1.3 237285_at SORBS2 sorbin and SH3 domain containing 2
723 0.0003169 -1.19 202550_s_at VAPB VAMP (vesicle-associated membrane protein)-associated protein B and C
724 0.0003084 -1.34 201461_s_at MAPKAPK2 mitogen-activated protein kinase-activated protein kinase 2
725 0.0003068 -1.11 1563069_at NA NA
726 0.0002955 -1.14 218382_s_at U2AF2 U2 small nuclear RNA auxiliary factor 2
727 0.0002940 -1.11 205570_at PIP4K2A phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
728 0.0002921 -1.28 208642_s_at XRCC5 X-ray repair complementing defective repair in Chinese hamster cells 5
(double-strand-break rejoining)
729 0.0002910 -1.24 221603_at PEX16 peroxisomal biogenesis factor 16
730 0.0002863 -1.21 231211_s_at LOC541469 hypothetical protein LOC541469
731 0.0002857 -2.02 219062_s_at ZCCHC2 zinc finger, CCHC domain containing 2
732 0.0002808 -1.2 218570_at KBTBD4 kelch repeat and BTB (POZ) domain containing 4
733 0.0002799 -1.16 223545_at FANCD2 Fanconi anemia, complementation group D2
734 0.0002764 -1.34 1555614_at SUGT1P suppressor of G2 allele of SKP1 pseudogene (S. cerevisiae)
735 0.0002736 -1.53 1556283_s_at FGFR1OP2 FGFR1 oncogene partner 2
736 0.0002703 -1.66 226022_at SASH1 SAM and SH3 domain containing 1
737 0.0002699 -1.87 214838_at SFT2D2 SFT2 domain containing 2
738 0.0002674 -1.26 206307_s_at FOXD1 forkhead box D1
739 0.0002668 -1.41 208108_s_at AVPR2 arginine vasopressin receptor 2
740 0.0002633 -1.21 239949_at THNSL2 threonine synthase-like 2 (S. cerevisiae)
741 0.0002619 -1.76 1554096_a_at RBM33 RNA binding motif protein 33
742 0.0002577 -1.25 203039_s_at NDUFS1 NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-
coenzyme Q reductase)
743 0.0002569 -3.7 1563541_at NA NA
744 0.0002547 -1.33 210569_s_at SIGLEC9 sialic acid binding Ig-like lectin 9
745 0.0002484 -1.44 203922_s_at CYBB cytochrome b-245, beta polypeptide
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Table 1 Control vs Toxin corresponding P-value p<0.001 (Continued)
746 0.0002482 -1.33 220012_at ERO1LB ERO1-like beta (S. cerevisiae)
747 0.0002373 -2.41 236106_at NA NA
748 0.0002362 -1.34 242834_at NA NA
749 0.0002316 -1.2 220498_at ACTL7B actin-like 7B
750 0.0002303 -1.44 240873_x_at DAB2 disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)
751 0.0002296 -1.19 221471_at SERINC3 serine incorporator 3
752 0.0002267 -1.74 213236_at SASH1 SAM and SH3 domain containing 1
753 0.0002262 -1.62 213988_s_at 04/01/12 spermidine/spermine N1-acetyltransferase 1
754 0.0002220 -1.2 239372_at NA NA
755 0.0002208 -1.35 240079_at ZNF81 zinc finger protein 81
756 0.0002182 -1.65 205227_at IL1RAP interleukin 1 receptor accessory protein
757 0.0002149 -1.5 223751_x_at TLR10 toll-like receptor 10
758 0.0002132 -1.35 1553677_a_at TIPRL TIP41, TOR signaling pathway regulator-like (S. cerevisiae)
759 0.0002103 -1.44 AFFX-
HUMISGF3A/
M97935_5_at
STAT1 signal transducer and activator of transcription 1, 91kDa
760 0.0002103 -1.11 202240_at PLK1 polo-like kinase 1 (Drosophila)
761 0.0002099 -1.28 1556281_at NA NA
762 0.0002093 -1.53 222989_s_at UBQLN1 ubiquilin 1
763 0.0002070 -1.16 204682_at LTBP2 latent transforming growth factor beta binding protein 2
764 0.0002018 -1.37 225830_at PDZD8 PDZ domain containing 8
765 0.0002016 -1.34 229208_at CEP27 centrosomal protein 27kDa
766 0.0002006 -1.38 202211_at ARFGAP3 ADP-ribosylation factor GTPase activating protein 3
767 0.0001969 -1.21 208696_at CCT5 chaperonin containing TCP1, subunit 5 (epsilon)
768 0.0001905 -1.71 219207_at EDC3 enhancer of mRNA decapping 3 homolog (S. cerevisiae)
769 0.0001804 -1.31 221248_s_at WHSC1L1 Wolf-Hirschhorn syndrome candidate 1-like 1
770 0.0001758 -1.59 211781_x_at NA NA
771 0.0001730 -1.36 226037_s_at TAF9B TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated
factor, 31kDa
772 0.0001724 -1.14 200901_s_at M6PR mannose-6-phosphate receptor (cation dependent)
773 0.0001713 -1.67 213173_at PCNX pecanex homolog (Drosophila)
774 0.0001667 -2.06 206038_s_at NR2C2 nuclear receptor subfamily 2, group C, member 2
775 0.0001616 -1.24 225397_at C15orf57 chromosome 15 open reading frame 57
776 0.0001297 -2.14 211367_s_at CASP1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta,
convertase)
777 0.0001209 -1.66 222810_s_at RASAL2 RAS protein activator like 2
778 0.0001196 -1.23 231718_at SLU7 SLU7 splicing factor homolog (S. cerevisiae)
779 0.0001187 -1.32 223905_at CCDC135 coiled-coil domain containing 135
780 0.0001127 -1.28 211672_s_at ARPC4 actin related protein 2/3 complex, subunit 4, 20kDa
781 0.0001127 -1.38 200828_s_at ZNF207 zinc finger protein 207
782 0.0001073 -1.29 244211_at NA NA
783 0.0001070 -12.04 205403_at IL1R2 interleukin 1 receptor, type II
784 0.0001065 -1.83 209970_x_at CASP1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta,
convertase)
785 0.0001034 -6.35 217502_at IFIT2 interferon-induced protein with tetratricopeptide repeats 2
786 0.0001029 -2.07 237867_s_at PID1 phosphotyrosine interaction domain containing 1
787 0.0001028 -1.26 218516_s_at IMPAD1 inositol monophosphatase domain containing 1
788 9.94E-005 -1.64 226312_at RICTOR rapamycin-insensitive companion of mTOR
789 9.41E-005 -1.2 210940_s_at GRM1 glutamate receptor, metabotropic 1
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over-expression of RGS14, thereby inhibiting G-protein
mediated signaling required for actin-based motility.
RGS14 expression is down-regulated during the mat-
uration of monocytes to dendritic cells [24] and over-
expression of this G-protein regulator would be expected
to block monocyte maturation. RGS14 levels are also
known to decrease in dendritic cells exposed to Leishmania
major or Toxoplasma gondii, suggesting that RGS14 down-
regulation may be an important step in a normal immune
response, and up-regulation of RGS14 by LT could be
contributing to LT’s immunosuppressive effects [25].
Three chemokine receptors were also altered after LT
treatment, suggesting that LT may be inducing functional
defects in monocyte response signaling. IL-8 receptor beta
(CXCR2) was up-regulated after LT treatment (Table 2).
CXCR2 transduces signaling through a G-protein activated
second messenger system. This receptor is important
for monocyte transendothelial migration, and up-
regulation of CXCR2 could serve to enhance the deliv-
ery of monocytes to tissues. Anthrax spores must be
phagocytosed by macrophages in order to germinate
into viable bacteria. An increase in the macrophage
pool may aid in a reservoir for increased germination of
viable bacteria. IL-1 receptor type II (IL-1R2), was
found to be markedly down-regulated. IL-1R2 is a
decoy receptor for IL-1 that functions either at the cell
surface or in a soluble form [26]. The decreased expres-
sion of the decoy receptor would presumably increase
IL-1a levels and increase the febrile response of the
host potentially at least in part explaining the high fever
that commonly accompanies systemic anthrax [27].
CCR5 is a receptor for the monocyte chemokines
Table 1 Control vs Toxin corresponding P-value p<0.001 (Continued)
790 9.02E-005 -1.36 1554556_a_at ATP11B ATPase, class VI, type 11B
791 8.89E-005 -1.14 226735_at TAPT1 transmembrane anterior posterior transformation 1
792 8.70E-005 -3.84 213006_at CEBPD CCAAT/enhancer binding protein (C/EBP), delta
793 8.35E-005 -1.31 207787_at KRT33B keratin 33B
794 8.34E-005 -1.29 207410_s_at TLX2 T-cell leukemia homeobox 2
795 8.21E-005 -1.6 223596_at SLC12A6 solute carrier family 12 (potassium/chloride transporters), member 6
796 7.98E-005 -1.23 231859_at C14orf132 chromosome 14 open reading frame 132
797 7.81E-005 -1.25 228277_at FBXL19 F-box and leucine-rich repeat protein 19
798 7.75E-005 -1.35 210470_x_at NONO non-POU domain containing, octamer-binding
799 7.52E-005 -1.29 222432_s_at CCDC47 coiled-coil domain containing 47
800 7.19E-005 -1.8 238496_at NA NA
801 7.11E-005 -1.38 208698_s_at NONO non-POU domain containing, octamer-binding
802 7.08E-005 -4.66 203946_s_at ARG2 arginase, type II
803 7.03E-005 -1.17 1559952_x_at LOC100132923 similar to hCG1993470
804 6.19E-005 -2.35 220104_at ZC3HAV1 zinc finger CCCH-type, antiviral 1
805 5.57E-005 -2.43 203595_s_at IFIT5 interferon-induced protein with tetratricopeptide repeats 5
806 5.53E-005 -1.33 1569859_at NA NA
807 5.31E-005 -1.5 224359_s_at HOOK3 hook homolog 3 (Drosophila)
808 4.19E-005 -2.51 205921_s_at SLC6A6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6
809 3.18E-005 -2.18 205749_at CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1
810 2.93E-005 -1.38 1566136_at NA NA
811 2.02E-005 -1.51 210992_x_at FCGR2C Fc fragment of IgG, low affinity IIc, receptor for (CD32)
812 1.61E-005 -1.22 207801_s_at RNF10 ring finger protein 10
813 1.32E-005 -2.03 222816_s_at ZCCHC2 zinc finger, CCHC domain containing 2
814 1.29E-005 -1.25 211884_s_at CIITA class II, major histocompatibility complex, transactivator
815 8.60E-006 -1.68 212664_at TUBB4 tubulin, beta 4
816 4.60E-006 -1.16 212081_x_at BAT2 HLA-B associated transcript 2
817 3.60E-006 -1.21 1554177_a_at ATP5S ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s
(factor B)
818 7.00E-007 -1.82 224783_at FAM100B family with sequence similarity 100, member B
819 6.00E-007 -1.57 208840_s_at G3BP2 GTPase activating protein (SH3 domain) binding protein 2
820 4.00E-007 -1.59 206717_at MYH8 myosin, heavy chain 8, skeletal muscle, perinatal
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RANTES and MIP. The down-regulation of CCR5 by
LT could reflect an inability of toxin-treated monocytes
to differentiate into macrophages [28] (Table 2). During
the early stages of infection, macrophages play a critical
role in assisting B. anthracis pathogenesis by providing
a place for bacteria germination from their spore form
to viable bacteria. An increase in monocyte trafficking to
allow an increase in spore uptake and subsequent germin-
ation would prove beneficial for B. anthracis. During later
stages of infection, after release of viable bacteria, limiting
monocyte differentiation to macrophages would assist in
preventing clearance of viable bacteria.
In addition to an alteration in the chemokine response
by LT, an additional enzyme, heparanase (HPSE), was
found to be decreased in LT-treated human monocytes.
This enzyme is an endoglycosidase that degrades heparin
sulfate, resulting in disassembly of extracellular barriers
required for cell migration [29]. Heparanase has also been
postulated to play a role in inflammation [30] and our
results showed a 2.6 fold decrease in heparanase gene ex-
pression (Table 2). One study has concluded that an
in vivo siRNA against heparanase, along with an inhibitor
of its enzymatic activity, results in a diminished inflamma-
tory response [31]. Thus LT- mediated inhibition of hepar-
anase expression could also contribute to the inhibition of
the host immune response during an anthrax infection.
















































h_mapkPathway MAPKinase Signaling Pathway 228 0.00001
h_p38mapkPathway p38 MAPK Signaling Pathway 103 0.00001
h_il18Pathway IL 18 Signaling Pathway 9 0.00004
h_tollPathway Toll-Like Receptor Pathway 87 0.00028
h_ifnaPathway IFN alpha signaling pathway 25 0.00043
h_gpcrPathway Signaling Pathway from G-Protein Families 70 0.00044
h_p53hypoxiaPathway Hypoxia and p53 in the Cardiovascular system 67 0.00191
h_arenrf2Pathway Oxidative Stress Induced Gene Expression Via Nrf2 51 0.00418
Biocarta # of       
Pathway DescriptionPathway genes P-value  
(C)
Figure 3 Supervised microarray analysis. A.) Hierarchical cluster analysis showing the 820 probe sets which were differentially expressed at
the 0.001 significance level. The arrays clustering on the left are from control samples, whereas the cluster on the right shows the LT treated
samples. Up-regulated genes are shown in red and down-regulated genes are shown in blue. B.) Biocarta pathway analysis showing the
pathways most significantly affected by LT, along with the number of genes and p-value within each pathway that were affected. C.) Correlation
of genes altered after treatment with anthrax LT using microarray analysis versus RT-PCR. Spearman correlation coefficient = 0.885.
Table 2 Predicted effects of LT on monocyte function.1
Gene Microarray Effects
RGS-14 5.61 Blockade of monocyte maturation to dendritic
cells, inhibition of chemotaxis
CXCR2 5.04 Increased monocyte transendothelial migration
into tissues
HPSE -2.58 Diminished inflammatory response
CCR5 -2.33 Reduced responsiveness to the inflammatory
mediators RANTES, MIP1 beta
ILIR2 -12.5 Increased IL1 alpha responsiveness and
increased fever
1 Calculated fold changes compared to mock treated samples.
Chauncey et al. BMC Immunology 2012, 13:33 Page 23 of 26
http://www.biomedcentral.com/1471-2172/13/33
An external verification method using quantitative
real-time PCR was utilized to confirm the microarray
data. The eight genes corresponding to RGS14, IL8RB,
TLR5, PPM1H, CD47, SYK, CCR5, and IL1R2 were
chosen for microarray confirmation in monocytes. CCR5
and IL1R2 were confirmed to be down-regulated at 4 h
after LT treatment, reinforcing the microarray data,
while the other six genes were up-regulated, again con-
firming the microarray data (Table 3). A correlation
curve was plotted (Figure 3C) and analyzed, showing a
linear relationship between the microarray results and
RT-PCR with a correlation coefficient of 0.885. Results
were performed in duplicates and fold values were
normalized to GAPDH. To exclude the possibility the
lymphocyte contamination might be contributing to our
microarray findings, a higher purity monocyte popula-
tion (98% purity), obtained by adherence followed by
washing off non-adherent lymphocytes, was treated with
500 ng/mL LT for 4 h and gene expression was assessed
using real-time PCR. These experiments verified 3 genes
to be increased after LT treatment: RGS14, TLR5, and
CD47 (1.21-1.70), as observed by the microarray of sus-
pended cells. These findings suggest that the changes in
messenger RNA observed are primarily contributed by
monocytes, but we cannot entirely exclude a contribu-
tion by lymphocytes.
Conclusions
Our investigations show human peripheral monocytes
are susceptible to the actions of anthrax LT and do not
undergo LT-mediated cytotoxicity after a four hour toxin
treatment. We also find that LT induces changes in sev-
eral genes involved in previously unidentified pathways
including the TLR pathway, IFN alpha pathway, and G-
Protein family signaling pathways. The identification of
several previously unappreciated gene products includ-
ing RGS14, IL8 receptor beta, CD47, TNF ligand, IL-16,
Syk, CCR5, and IL-1 receptor II adds to our understand-
ing of how LT impacts the immune response. Our path-
way analysis reveals that anthrax LT targets multiple
normal immune-regulatory pathways that would be
expected to protect the host against anthrax infection.
The increase in RGS14 levels and decrease in CCR5,
along with IL-1R2, would likely impair monocyte func-
tions and help to facilitate bacteria survival. B. anthracis
maintains a selective advantage by impairing the host
immune responses, thereby allowing for invasion and
dissemination of the highly fatal bacilli. Our findings en-
courage further investigations into how these pathways
converge functionally to impair normal monocyte func-
tion, along with providing new insights into the regula-
tion of the host defense system and inflammation.
Methods
Monocyte isolation and toxin treatment
Whole blood was collected by venous puncture from
healthy human volunteers into 8 mL vacutainer tubes con-
taining Ficoll (BD Biosciences). The study followed US
Department of Health and Human Services guidelines and
was approved by the University of Florida Institutional Re-
view Board. Whole blood was incubated with a monocyte
negative selection antibody (Stem Cell Technologies) for
Table 3 q-RTPCR confirmation of LT-induced genes.1
Probe Microarray q-RT-PCR Gene name Primer sequence
38290_at 5.61 7.40 RGS14-F CAGGGATCTGTGAGAAACGAG
RGS14-R AGGTGATCCTGTTTTCCAGC
207008_at 5.04 7.50 IL8RB-F GTCTAACAGCTCTGACTACCAC
L8RB-R TTAAATCCTGACTGGGTCGC
210166_at 3.90 2.24 TLR5-F TTTTCAGGAGCCCGAGC
TLR5-R AGCCGAGATTGTGTCACTG
212686_at 2.65 3.85 PPM1H-F GAGTACAGAGAAAGGAGCTTGG
PPM1H-R TCCAATAGTTGCCATTACCCG
226016_at 2.38 1.60 CD47-F TTTGCTATACTCCTGTTCTGGG
CD47-R TGGGACGAAAAGAATGGCTC
209269_at 2.15 1.60 SYK-F CAAGTTCTCCAGCAAAAGCG
SYK-R CATCCGCTCTCCTTTCTCTAAC
206991_at -2.66 -2.33 CCR5-F CCAAAAGCACATTGCCAAACG
CCR5-R ACTTGAGTCCGTGTCACAAGCC
205403_at -12.5 -28.0 IL1R2-F TGGCACCTACGTCTGCACTACT
IL1R2-R TTGCGGGTATGAGATGAACG
1 Calculated fold changes comparedtomock treated samples.
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20 min., centrifuged 1700 × g for 25 min at RT, no brake
over Ficoll, re-suspended in 10 mL RPMI (Mediatech)
complete media, centrifuged at 250 × g for 9 min. to re-
move platelets, and re-suspended to 7-9 × 105 cells/mL in
RPMI. Monocytes were inverted at 37°C with 500 ng/mL
LF and 500 ng/mL PA for 4 h. Additional qRT-PCR
experiments were performed using higher monocyte
purities (98%), obtained by first using a negative selection
antibody cocktail (Stem Cell Technologies) isolation tech-
nique, followed by plastic adherence for 4 h, as described
previously [32].
Toxin purification
LF and PA were purified as previously described [33].
Briefly, Bacillus anthracis culture media was filtered
through a 0.22 uM filter, followed by diethylaminoethyl
cellulose (DEAE) anion exchange chromatography. The
toxins were then subjected to gel filtration and hydro-
phobic interaction fast protein liquid chromatography
(FPLC) and highly purified toxin components were con-
firmed by Coomassie Blue staining.
Monocyte purity and apoptosis analysis
Monocytes were inverted at 37°C with 500 ng/mL LF and
500 ng/mL PA for 4 h, stained with CD-14 Pac Blue (BD
Biosciences), Annexin-V-Fluorescein and propidium
iodide (Roche). The cell population was gated first for
CD14-Pac-Blue followed by analysis of the relative
amount of Annexin (FL1) and PI (FL2) using flow cyto-
metry FACScan (BD), and analyzed by FCS Express
(De Novo).
MEK cleavage
Purified monocytes were incubated at 37°C with 500 ng/
mL lethal toxin for 4 h. Cells were lysed, ran on a 10%
SDS-PAGE gel (Pierce), transferred to a PVDF mem-
brane (Bio-rad) and probed for MEK1 (Upstate). Mem-
branes were then stripped and probed for MEK3 (Santa
Cruz). β-actin (Sigma) was used to check consistent
loading amounts.
RNA isolation
Purified monocytes from 4 healthy volunteers were incu-
bated at 37°C with media alone or with 500 ng/mL LT
for 4 h. Total RNA was collected using RNAeasy mini
kit (Qiagen) and RNA quantity and quality was assessed
using NanoDrop (Thermo Scientific) technology.
Microarray procedure
100 ng total RNA was labeled using Affymetrix Gene-
ChipW 3' IVT Express Kit for each replicate. Amplified
labeled RNA was purified, fragmented, then hybridized
for 16 h on Affymetrix GeneChipsW (HG U133 plus 2.0)
representing approximately 22,000 well-characterized
human genes. Arrays were washed using Affymetrix
GeneChipW Fluidics Station FS450 and scanned using
GeneChipW Scanner 3000 7 G.
Microarray analysis
Low-level analysis was performed using dChipmodeled-
based expression matrix (dChip 2007 (DNA-Chip
Analyzer), Build date: Jan 4, 2008). Unsupervised analysis
- probes sets whose hybridization signal intensity exhib-
ited a coefficient of variation of greater than 0.5 were ana-
lyzed by unsupervised hierarchical cluster analysis using
algorithms implemented in dChip. Supervised analysis -
significant probe sets between the treatment groups were
identified using a paired t-test (by donor) at a significance
threshold of p< 0.001. Leave-one-out-cross-validation
using 4 prediction models was used to test the ability of
probe sets significant at p< 0.001 to distinguish between
the treatment groups. Microarray analyses were done
using dCHIP and BRB-ArrayTools by Richard Simon
(http://linus.nci.nih.gov/BRB-ArrayTools.html). The micro-
array data for this study was deposited in the National Cen-
ter for Biotechnology Information (NCBI) Gene Expression
Omnibus (GEO) [30] with accession numbersGSM848717
through GSM 848724. The microarray data is also available
in a series with accession number GSE34407.
Quantitative real time-PCR (qRT-PCR)
RNA was collected using RNAeasy mini kit (Qiagen),
quantitated using a Nanodrop system (Thermo Scientific),
and 233 μg total RNA was used for cDNAsynthesis using
SuperScript III First-Strand Synthesis (Invitrogen). cDNA
was quantitated using SYBR Green JumpStart TaqReady-
Mix (Sigma) and 10 mM forward and 10 mM reverse pri-
mers were used for each indicated reaction. Primers used
were as follows ACTB-F TCACCGAGCGCGGCT,ACTB-
R TAATGTCACGCACGATTTCCC,GAPDH-F GGTGAA
GGTCGGAGTCAACG, and GAPDH-R AGAGTTAAAA
GCAGCCCTGGTG. All other primers are listed in Table 2.
Reactions were run on the MJR Opticon Continuous Fluor-
escence detector (Bio-Rad) and analyzed with Opticon
Monitor Software 1.08 (Bio-Rad).
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